Cargando…

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer

Despite good responses to first-line treatment with platinum-based combination chemotherapy, most ovarian cancer patients will relapse and eventually develop platinum-resistant disease with poor prognosis. Although reports suggest that integrin-linked kinase (ILK) is a potential target for ovarian c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reyes-González, Jeyshka M., Quiñones-Díaz, Blanca I., Santana, Yasmarie, Báez-Vega, Perla M., Soto, Daniel, Valiyeva, Fatima, Marcos-Martínez, María J., Fernández-de Thomas, Ricardo J., Vivas-Mejía, Pablo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226328/ https://www.ncbi.nlm.nih.gov/pubmed/32260415 http://dx.doi.org/10.3390/cancers12040880

Ejemplares similares

MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer
por: Quiñones-Díaz, Blanca I., et al.
Publicado: (2020)

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022)

Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022)

c-MYC and Epithelial Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2021)

Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
por: Echevarría-Vargas, Ileabett M., et al.
Publicado: (2014)

Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells
por: Báez-Vega, Perla M., et al.
Publicado: (2016)

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer.
por: Reyes-Gonzalez, Jeyshka M., et al.
Publicado: (2019)

Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer
por: Noriega-Rivera, Ricardo, et al.
Publicado: (2022)

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2020)

Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression
por: Lozada-Delgado, Eunice L., et al.
Publicado: (2018)

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2023)

Parvin-ILK: An intimate relationship
por: Vakaloglou, Katerina, et al.
Publicado: (2012)

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
por: Elahi Najafi, Mohammad Amin, et al.
Publicado: (2023)

ILK Induces Cardiomyogenesis in the Human Heart
por: Traister, Alexandra, et al.
Publicado: (2012)

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
por: Jiang, Guiyang, et al.
Publicado: (2021)

Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2021)

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
por: Lu, Jingjing, et al.
Publicado: (2017)

The evolutionary history of effectors downstream of Cdc42 and Rac
por: Cotteret, Sophie, et al.
Publicado: (2002)

Ras Downstream Effector GGCT Alleviates Oncogenic Stress
por: He, Zaoke, et al.
Publicado: (2019)

Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer
por: Sun, Zhangyue, et al.
Publicado: (2023)

Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by down Regulating ILK in vitro and in vivo [Retraction]
Publicado: (2022)

Integrin-linked kinase (ILK) expression in human colon cancer
por: Bravou, V, et al.
Publicado: (2003)

ILK modulates epithelial polarity and matrix formation in hair follicles
por: Rudkouskaya, Alena, et al.
Publicado: (2014)

Non-catalytic signaling by pseudokinase ILK for regulating cell adhesion
por: Vaynberg, Julia, et al.
Publicado: (2018)

Integrin-linked kinase (ILK): the known vs. the unknown and perspectives
por: Górska, Agata, et al.
Publicado: (2022)

Epithelial morphogenesis in the Drosophila egg chamber requires Parvin and ILK
por: Keramidioti, Athina, et al.
Publicado: (2022)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection
por: Hu, Ming-Chang, et al.
Publicado: (2013)

Signaling Pathways and Downstream Effectors of Host Innate Immunity in Plants
por: Kumar, Jitendra, et al.
Publicado: (2021)

The Impairment of ILK Related Angiogenesis Involved in Cardiac Maladaptation after Infarction
por: Xie, Jun, et al.
Publicado: (2011)

PARVA Promotes Metastasis by Modulating ILK Signalling Pathway in Lung Adenocarcinoma
por: Huang, Ay-Huey, et al.
Publicado: (2015)

An ELMO2-RhoG-ILK network modulates microtubule dynamics
por: Jackson, Bradley C., et al.
Publicado: (2015)

NRP2 transcriptionally regulates its downstream effector WDFY1
por: Dutta, Samikshan, et al.
Publicado: (2016)

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016)

Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway
por: Lu, Jingjing, et al.
Publicado: (2016)

GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway
por: Feng, Ying, et al.
Publicado: (2021)

Gender-Based Differences in Cardiac Remodeling and ILK Expression after Myocardial Infarction
por: Sofia, Renato Rodrigues, et al.
Publicado: (2014)

Integrin linked kinase (ILK) regulates podosome maturation and stability in dendritic cells()
por: Griera, Mercedes, et al.
Publicado: (2014)

ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma
por: Ma, Xiao-Li, et al.
Publicado: (2019)

New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis
por: McDonald, Paul C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cism9nsg0618bgv2j0ejic9ng7